J. L. Bainbridge & Co., Inc. - ATOSSA THERAPEUTICS INC ownership

ATOSSA THERAPEUTICS INC's ticker is ATOS and the CUSIP is 04962H506. A total of 99 filers reported holding ATOSSA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.75 and the average weighting 0.0%.

Quarter-by-quarter ownership
J. L. Bainbridge & Co., Inc. ownership history of ATOSSA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$8,191
-38.8%
11,121
+4.7%
0.00%
-50.0%
Q2 2023$13,382
+73.8%
10,6210.0%0.00%
+100.0%
Q1 2023$7,699
+37.2%
10,6210.0%0.00%0.0%
Q4 2022$5,613
-37.6%
10,6210.0%0.00%0.0%
Q3 2022$9,000
-25.0%
10,6210.0%0.00%
-50.0%
Q2 2022$12,000
-7.7%
10,6210.0%0.00%
+100.0%
Q1 2022$13,000
-23.5%
10,6210.0%0.00%
-50.0%
Q4 2021$17,000
-51.4%
10,6210.0%0.00%
-50.0%
Q3 2021$35,000
-47.8%
10,6210.0%0.00%
-50.0%
Q2 2021$67,00010,6210.01%
Other shareholders
ATOSSA THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 65,714$47,6360.04%
Laurion Capital Management LP 2,225,800$1,613,4820.01%
ETF MANAGERS GROUP, LLC 42,442$30,7660.00%
EDMOND DE ROTHSCHILD HOLDING S.A. 50,000$36,2450.00%
Renaissance Technologies 936,070$6790.00%
Caption Management, LLC 75,000$54,3680.00%
St. Johns Investment Management Company, LLC 1,550$1,1240.00%
J. L. Bainbridge & Co., Inc. 10,621$7,6990.00%
D. E. Shaw & Co., Inc. 823,362$596,8550.00%
WELLS FARGO & COMPANY/MN 5,023$3,6420.00%
View complete list of ATOSSA THERAPEUTICS INC shareholders